A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study

  • Janet S. Rader
  • , Michael W. Sill
  • , Jan H. Beumer
  • , Heather A. Lankes
  • , Doris Mangiaracina Benbrook
  • , Francisco Garcia
  • , Connie Trimble
  • , J. Tate Thigpen
  • , Richard Lieberman
  • , Rosemary E. Zuna
  • , Charles A. Leath
  • , Nick M. Spirtos
  • , John Byron
  • , Premal H. Thaker
  • , Shashikant Lele
  • , David Alberts

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology